Association between post-Kasai cholangitis episodes, ursodeoxycholic acid regimen, and portal hypertension risk in biliary atresia: a multicenter cross-sectional study
Pediatric Surgery International · 13.06.2026 · 42 (1)
DOI: 10.1007/s00383-026-06501-8 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Surgery International, online erschienen am 13.06.2026. Verfasst von Qianhui Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China. Hauptthemen laut MEDLINE: Ursodeoxycholic Acid, Hypertension, Portal, Biliary Atresia, Cholangitis. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Tianshan Talent Training Program, Xinjiang Uygur Autonomous Region Science Foundation Projects, Tianjin Applied Basic Research Project.
Abstract (Originalsprache)
BACKGROUND: To investigate the association between cholangitis and portal hypertension (PH) risk, and the efficacy of UDCA in native liver survivors after successful Kasai portoenterostomy (KPE). METHODS: A multicenter, retrospective cross-sectional study was conducted at nine Chinese pediatric centers. Patient grouping was based on cumulative cholangitis episodes and UDCA regimens. RESULTS: After a median follow-up of 56 months, the overall incidence of PH was 23.63% (198/838). Recurrent cholangitis (≥ 3 episodes) was an independent risk factor for PH (OR = 4.25, 95% CI 2.61-6.92, P < 0.001), associated with poorer liver function recovery, greater spleen thickness, and lower peak velocity of the main portal vein. Continuous UDCA therapy significantly attenuated the PH risk induced by recurrent cholangitis (RERI: - 7.66). Among this high-risk subgroup, low-dose UDCA (≤ 10 mg/kg/day) constituted an independent protective factor (OR = 0.17, 95%CI 0.04-0.67, P = 0.015) and showed superior efficacy in reducing total bilirubin. These benefits were evident in children under 48 months, but no clear advantage observed beyond this age. CONCLUSION: Among native liver survivors with jaundice clearance, recurrent cholangitis (≥ 3 episodes) warrants long-term monitoring for PH. Continuous low-dose UDCA until 48 months is recommended for high-risk patients to improve outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical School of Pediatrics, Tianjin Medical University, Tianjin, China.
- Department of General Surgery, Tianjin Children's Hospital (Children's Hospital of Tianjin University), Tianjin, China.
- Department of General Surgery, Urumqi Children's Hospital, Xinjiang, China.
- Shanxi Provincial Children's Hospital, Taiyuan, China.
- Department of Neonatal Surgery, Xi'an Children's Hospital, Xi'an, Shaanxi, China.
- Department of Pediatric Surgery, Tongji Medical College, Wuhan Children's Hospital (Wuhan Maternal and Child Healthcare Hospital, Huazhong University of Science and Technology, Wuhan, China.
Förderung
- Tianshan Talent Training Program
- Xinjiang Uygur Autonomous Region Science Foundation Projects
- Tianjin Applied Basic Research Project
- Tianjin Key Medical Discipline(Specialty) Construction Project
Zitieren
APA
Yang, Q., Meng, Y., Li, X., Yang, Y., Wu, X., Yu, P., Yan, X., Wang, B., Zhang, Z., Zhang, X., Yang, T., Abudureyimu, A., Gao, W., & Zhan, J. (2026). Association between post-Kasai cholangitis episodes, ursodeoxycholic acid regimen, and portal hypertension risk in biliary atresia: a multicenter cross-sectional study. Pediatric Surgery International, 42(1). https://doi.org/10.1007/s00383-026-06501-8
Vancouver
Yang Q, Meng Y, Li X, Yang Y, Wu X, Yu P, et al. Association between post-Kasai cholangitis episodes, ursodeoxycholic acid regimen, and portal hypertension risk in biliary atresia: a multicenter cross-sectional study. Pediatric Surgery International. 2026;42(1). doi:10.1007/s00383-026-06501-8
BibTeX
@article{Yang2026,
author = {Yang, Qianhui and Meng, Yu and Li, Xin and Yang, Yuan and Wu, Xiaoxia and Yu, Pu and Yan, Xueqiang and Wang, Bin and Zhang, Zhibo and Zhang, Xianwei and Yang, Tiquan and Abudureyimu, Alimujiang and Gao, Wei and Zhan, Jianghua},
title = {Association between post-Kasai cholangitis episodes, ursodeoxycholic acid regimen, and portal hypertension risk in biliary atresia: a multicenter cross-sectional study},
journal = {Pediatric Surgery International},
year = {2026},
volume = {42},
number = {1},
doi = {10.1007/s00383-026-06501-8}
}
EUVIMED